caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1194820266

Asra KermaniMD

EndocrinologyDallas, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (3)

CCN 450015
Hospital
CCN 450044
Hospital
CCN 450352
Hospital
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$101
Payment records
1
By payment type
Food and Beverage$101
QUALITY · MIPS · 2024
Final MIPS score
82.9
Quality
70.2
Cost
72.8
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.33%
Group
REFERRAL NETWORK

Where Asra Kermani's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 5 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Laboratory Corporation Of America
Clinical Laboratory · Dallas, TX
1933
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER AT DALLAS1958
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER AT DALLAS2172
The University Of Texas Southwestern Medical Center At Dallas
Clinical Laboratory · Dallas, TX
2040
DALLAS COUNTY HOSPITAL DISTRICT20113
Laboratory Corporation Of America
Clinical Laboratory · Dallas, TX
1838
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Irving, TX
1639
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
1,159
Beneficiaries
—
Total drug cost
$575K
Distinct drugs
26
Brand share
59.6%
Top prescribed drugs
Levothyroxine Sodium185 claims
Semaglutide107 claims
Levothyroxine Sodium88 claims
Tirzepatide73 claims
Metformin Hcl68 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
253
Unique beneficiaries
—
Total services
363
Distinct HCPCS
4
Medicare payment
$29K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 484 Endocrinology providers in TX — below median (cohort median 868).